Instrument Inactif

Autres langues Probi AB

Actions

PROB

SE0001280355

Produits pharmaceutiques

Autres langues

19/11	Probi Expands Its Probiotic Offering with Two New Areas: Sports & Active Nutrition and Pets
27/10/25	BLIS Technologies Limited Signs Agreement with Probi AB to Strengthen Alliance
03/02/25	Probi Gets Bourse Approval to Delist from Nasdaq Stockholm
03/02/25	Probi To Delist, Last Trading Day Is Feb 12, 2025
03/02/25	Delisting of Probi
29/01/25	Symrise AG completed the acquisition of remaining 30.35% stake in Probi AB (OM:PROB) from Fourth Swedish National Pension Fund, Moneta Asset Management and others.
21/01/25	Probi's Board Plans Delisting from Nasdaq Stockholm
20/01/25	Notice of Extraordinary General Meeting in Probi AB (publ)
20/01/25	Probi applies for delisting and convenes an Extraordinary General Meeting
20/01/25	Probi AB(OM:PROB) dropped from OMX Nordic All-Share Index
16/01/25	Symrise Owns Over 97% Stake in Probi; Offer Period Extends
10/01/25	Symrise Gains Swedish Regulatory Clearance for Proposed Takeover of Probi
09/01/25	Probi postpones year-end report 2024
09/01/25	Probi AB Postpones Year-End Report 2024
13/12/24	Probi's Independent Bid Committee Backs Symrise's Takeover Offer
13/12/24	Statement from the independent bid committee of Probi in relation to the public takeover offer by Symrise
27/11/24	Symrise Secures 90% Stake in Probi
20/11/24	Etwas leichter vor Nvidia-Zahlen
20/11/24	XETRA-SCHLUSS/DAX schließt knapp über der 19.000 - Brenntag gesucht
20/11/24	Global markets live: Pfizer, Alphabet, Comcast, Ford, Nokia...
20/11/24	Symrise will profitabler werden - Aktienkurs kaum bewegt
20/11/24	MIDDAY BRIEFING - Unternehmen und Märkte -2-
20/11/24	DAX bleibt komfortabel über 19.000er Marke
20/11/24	Symrise will schwedische Probi vollständig schlucken
20/11/24	Aktien auf Erholungskurs - Nvidia-Zahlen nächster Trigger